Production (Stage)
Bio-Techne Corporation
TECH
$46.78
-$0.54-1.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 6.45% | 2.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.45% | 2.62% | |||
| Cost of Revenue | 0.81% | -1.07% | |||
| Gross Profit | 9.32% | 4.60% | |||
| SG&A Expenses | 25.53% | 6.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.19% | 3.10% | |||
| Operating Income | -15.49% | 0.45% | |||
| Income Before Tax | -10.73% | 6.73% | |||
| Income Tax Expenses | 96.42% | 21.53% | |||
| Earnings from Continuing Operations | -35.26% | 3.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -35.26% | 3.84% | |||
| EBIT | -15.49% | 0.45% | |||
| EBITDA | -9.63% | -1.01% | |||
| EPS Basic | -34.83% | 3.92% | |||
| Normalized Basic EPS | -7.52% | -8.47% | |||
| EPS Diluted | -36.36% | 4.76% | |||
| Normalized Diluted EPS | -7.20% | -8.26% | |||
| Average Basic Shares Outstanding | -0.67% | -0.06% | |||
| Average Diluted Shares Outstanding | -1.05% | -0.30% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.53% | -0.03% | |||